1. Lachnit-Fixson U. Development and clinical evaluation of triphasic oral contraception. In: Elstein M, ed. Update on triphasic oral contraception. Amsterdam: Excerpta Medica. 1982;37–53.
2. Hofmeister H, Annen K, Laurent H, Petzoldt K, Wiechert R. Synthesen von Gestoden Drug Res. 1986;36:781–3.
3. Cullberg G, Lindstedt G, Lundberg P-A, Stefferson K. Central and peripheral effects of desogestrel 16–60 μg daily for 21 days in healthy female volunteers. Acta Obstet Gynecol Scand. 1982;111(suppl):47–54.
4. Düsterberg B, Beier S, Schneider WHF, Spona J. In: Breckwoldt M, Düsterberg B, eds. Gestodene a new direction in oral contraception. Carnforth: The Parthenon Publishing Group Ltd. 1988;13–29.
5. Elstein M. Gestodene: Development of a new gestodene-containing low-dose oral contraceptive. Carnforth: The Parthenon Publishing Group Ltd. 1987.